Entera Bio Ltd.

Developing innovative oral delivery of therapeutic proteins.

General Information
Company Name
Entera Bio Ltd.
Founded Year
2010
Location (Offices)
Founders / Decision Makers
Miranda Toledano - Chief Executive Officer and Board Member Dr. Phillip Schwartz - Founder and President Dr. Miriam Blum - Dr. Miriam Blum Dr. Hillel Galitzer - COO Spiros Jamas - Chief Executive Officer
Number of Employees
19
Industries
Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Post Ipo Equity
Social Media

Entera Bio Ltd. - Company Profile

Entera Bio Ltd. is a biotechnology startup with a focus on developing innovative oral delivery of therapeutic proteins. Founded in 2010, the company is currently conducting clinical trials on its proprietary technology that enables oral delivery of large molecules and biologics while enhancing their absorption in the GI tract. This addresses the challenges of oral drug delivery for large molecule APIs, including poor absorption and rapid degradation by enzymes and acids in the gastrointestinal tract.

Entera Bio's last investment of $6.60MPost-IPO Equity investment was made on 26 December 2023. The investment was aimed at further advancing their pioneering oral delivery technology. With a focus on biopharma, biotechnology, and pharmaceutical industries, Entera Bio is positioned to bring disruptive solutions to the healthcare sector.

Taxonomy: oral drug delivery, therapeutic proteins, clinical trials, proprietary technology, GI tract absorption, molecules and peptides protection, drug development, management team, pharmaceutical industry

Funding Rounds & Investors of Entera Bio Ltd. (4)

View All
Funding Stage Amount No. Investors Investors Date
Post-IPO Equity $6.60M - 26 Dec 2023
Post-IPO Equity $14.30M 1
Intuitive Venture Partners, investor in Entera Bio Ltd.'s Post-IPO Equity round
18 Dec 2019
Venture Round $2.02M - 18 Oct 2017
Venture Round $7.50M 1
Pontifax, investor in Entera Bio Ltd.'s Venture Round round
25 Jul 2016

Latest News of Entera Bio Ltd.

View All

No recent news or press coverage available for Entera Bio Ltd..

Similar Companies to Entera Bio Ltd.

View All
Ascelia Pharma AB - Similar company to Entera Bio Ltd.
Ascelia Pharma AB Ascelia Pharma is an oncology-dedicated orphan drug company listed on Nasdaq Stockholm under the ticker ACE.
TesoRx Pharma, LLC - Similar company to Entera Bio Ltd.
TesoRx Pharma, LLC
Syntara - Similar company to Entera Bio Ltd.
Syntara Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fibrosis and inflammation.
Exxel Pharma - Similar company to Entera Bio Ltd.
Exxel Pharma Advancing Breakthrough Therapeutics to Transform the Treatment of Neuronal Hypersensitivity Disorders.
Prilenia - Similar company to Entera Bio Ltd.
Prilenia Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorders.